Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,878,875
-$47,484 QoQ
Shares Held
69,416
-3.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#166
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOWER BRIDGE ADVISORS holds $63,752,721 across 8 Drug Manufacturers - General names. NVS ranks #2 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,561 | $22,745,806 | |
| 2 | NVS |
Novartis AG
This page
|
69,416 | $10,878,875 | |
| 3 | ABBV |
AbbVie Inc.
|
38,900 | $9,788,796 | |
| 4 | LLY |
ELI LILLY & Co
|
6,601 | $7,917,438 | |
| 5 | AMGN |
Amgen Inc
|
15,102 | $5,468,736 | |
| 6 | MRK |
Merck & Co., Inc.
|
34,852 | $4,478,482 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
26,527 | $1,528,485 | |
| 8 | PFE |
Pfizer Inc
|
39,290 | $946,103 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,878,875 | 69,416 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $10,926,359 | 71,531 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $9,775,120 | 70,901 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,404,865 | 73,338 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $8,996,367 | 74,344 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $8,688,193 | 77,935 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $7,716,974 | 79,303 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $9,355,266 | 81,336 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $8,874,718 | 83,362 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $8,218,954 | 84,968 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $9,189,279 | 91,010 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,379,065 | 92,078 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $9,405,720 | 93,209 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $9,719,708 | 105,649 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $9,808,646 | 108,120 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $8,410,506 | 110,650 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,606,242 | 113,643 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $10,106,079 | 115,169 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $10,418,551 | 119,110 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $11,211,547 | 137,094 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $12,740,844 | 139,641 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $12,153,973 | 142,185 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $13,736,543 | 145,468 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $12,393,800 | 142,523 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $12,125,412 | 138,830 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $10,745,213 | 130,324 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||